64x Bio
Enabling next generation medicines. A comprehensive platform and…
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out. 64x Bio is a Y Combinator company (Summer 2018). YC-listed status: Active.
- Website
- 64xbio.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- VectorSelect — Massively parallelized cell line engineering platform that accelerates manufacturing of gene and cell therapies. · Service · Enterprise
Links
- Y Combinator profileycombinator